Connection

Sakamuri Reddy to Cell Differentiation

This is a "connection" page, showing publications Sakamuri Reddy has written about Cell Differentiation.
Connection Strength

2.572
  1. Microgravity modulation of syncytin-A expression enhance osteoclast formation. J Cell Biochem. 2018 07; 119(7):5696-5703.
    View in: PubMed
    Score: 0.445
  2. Microgravity Induction of TRAIL Expression in Preosteoclast Cells Enhances Osteoclast Differentiation. Sci Rep. 2016 05 04; 6:25143.
    View in: PubMed
    Score: 0.390
  3. Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone. Endocrinology. 2011 Nov; 152(11):4180-9.
    View in: PubMed
    Score: 0.282
  4. Microarray profile of gene expression during osteoclast differentiation in modelled microgravity. J Cell Biochem. 2010 Dec 01; 111(5):1179-87.
    View in: PubMed
    Score: 0.268
  5. Osteoclast inhibitory peptide-1 binding to the Fc gammaRIIB inhibits osteoclast differentiation. Endocrinology. 2010 Sep; 151(9):4389-99.
    View in: PubMed
    Score: 0.260
  6. Functional characterization of human osteoclast inhibitory peptide-1 (OIP-1/hSca) gene promoter. Gene. 2006 Apr 12; 371(1):16-24.
    View in: PubMed
    Score: 0.190
  7. Inhibition of NFAM1 suppresses phospho-SAPK/JNK signaling during osteoclast differentiation and bone resorption. J Cell Biochem. 2021 10; 122(10):1534-1543.
    View in: PubMed
    Score: 0.140
  8. Microgravity control of autophagy modulates osteoclastogenesis. Bone. 2014 Apr; 61:125-31.
    View in: PubMed
    Score: 0.083
  9. NIP45 negatively regulates RANK ligand induced osteoclast differentiation. J Cell Biochem. 2012 Apr; 113(4):1274-81.
    View in: PubMed
    Score: 0.073
  10. Role of CXC chemokine ligand 13 in oral squamous cell carcinoma associated osteolysis in athymic mice. Int J Cancer. 2010 May 15; 126(10):2319-29.
    View in: PubMed
    Score: 0.064
  11. PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts. Blood. 2009 Mar 05; 113(10):2202-12.
    View in: PubMed
    Score: 0.058
  12. Osteoclast inhibitory peptide-1 (OIP-1) inhibits measles virus nucleocapsid protein stimulated osteoclast formation/activity. J Cell Biochem. 2008 Jul 01; 104(4):1500-8.
    View in: PubMed
    Score: 0.057
  13. RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation. Exp Cell Res. 2007 Jan 01; 313(1):168-78.
    View in: PubMed
    Score: 0.050
  14. RANK ligand expression in heat shock factor-2 deficient mouse bone marrow stromal/preosteoblast cells. J Cell Biochem. 2006 Apr 15; 97(6):1362-9.
    View in: PubMed
    Score: 0.049
  15. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J Clin Invest. 2004 Aug; 114(4):475-84.
    View in: PubMed
    Score: 0.043
  16. Regulatory mechanisms operative in osteoclasts. Crit Rev Eukaryot Gene Expr. 2004; 14(4):255-70.
    View in: PubMed
    Score: 0.041
  17. Kynurenine Promotes RANKL-Induced Osteoclastogenesis In Vitro by Activating the Aryl Hydrocarbon Receptor Pathway. Int J Mol Sci. 2020 Oct 26; 21(21).
    View in: PubMed
    Score: 0.033
  18. Fibulin-1 is required for bone formation and Bmp-2-mediated induction of Osterix. Bone. 2014 Dec; 69:30-8.
    View in: PubMed
    Score: 0.022
  19. Activation of NFAT signal in vivo leads to osteopenia associated with increased osteoclastogenesis and bone-resorbing activity. J Immunol. 2006 Aug 15; 177(4):2384-90.
    View in: PubMed
    Score: 0.012
  20. Annexin II stimulates RANKL expression through MAPK. J Bone Miner Res. 2005 Jul; 20(7):1161-7.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.